Brief: NovaBay Pharmaceuticals - Notified By FDA That It Declines To Review Co's EUA Request For Sars-Cov-2 IGG & IGM Antibody Combined Test Kits

Stablecoin Development

11/06/2021 22:18

June 11 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS - ON JUNE 7, NOTIFIED BY FDA THAT
IT
DECLINES TO REVIEW CO'S EUA REQUEST FOR SARS-COV-2 IGG & IGM
ANTIBODY COMBINED TEST KITS

Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))